跳至主要内容
临床试验/PACTR201611001569368
PACTR201611001569368已完成未知

Drospirenone containing combined oral contraceptive premedication before letrozole ovulation induction in clomiphene resistant PCOS, is it worth the wait?

Menoufia University - Faculty of mdicine0 个研究点目标入组 100 人开始时间: 2016年4月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 40 Year(s)(—)
性别
Female

入选标准

  • clomiphene resistant anovulatory polycystic ovary patients, normal hysterosalpingogram or laparoscopy; no recorded history of pelvic surgery and/or pelvic inflammatory disease, normal male semen analysis

排除标准

  • Presence of any infertility factors other than anovulatory PCOS, such as hyperprolactinemia, hypothalamic amenorrhea, premature ovarian failure, tubal or male factor infertility.

研究者

发起方
Menoufia University - Faculty of mdicine

相似试验